SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-035598
Filing Date
2022-12-15
Accepted
2022-12-15 16:52:42
Documents
70
Period of Report
2022-10-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 735232
2 ex31-1.htm EX-31.1 18621
3 ex31-2.htm EX-31.2 18460
4 ex32-1.htm EX-32.1 7976
5 ex32-2.htm EX-32.2 7551
  Complete submission text file 0001493152-22-035598.txt   4772693

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncs-20221031.xsd EX-101.SCH 39984
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT oncs-20221031_cal.xml EX-101.CAL 60217
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT oncs-20221031_def.xml EX-101.DEF 141410
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncs-20221031_lab.xml EX-101.LAB 342032
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncs-20221031_pre.xml EX-101.PRE 265605
64 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 751109
Mailing Address 24 N. MAIN STREET PENNINGTON NJ 08534
Business Address 24 N. MAIN STREET PENNINGTON NJ 08534 (858) 210-7333
ONCOSEC MEDICAL Inc (Filer) CIK: 0001444307 (see all company filings)

IRS No.: 980573252 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-54318 | Film No.: 221465467
SIC: 2834 Pharmaceutical Preparations